由於目前資訊產業趨於成熟，展望於二十一世紀，各國政府均將生技產業發展列為國家重要發展目標，於是生物科技產業及廠商之發展成為學術界與實務界極欲了解之課題。對於生技公司關於組織資本以及策略活動對生技公司經營績效的影響，以及組織資本、策略活動、財務能力、研發能力、經營績效五個變數之間的關聯性研究卻是相關文獻較少探討之課題。因此，本研究以此為研究動機提出下列四個研究目的：
1. 探討生技公司組織資本、策略活動、財務能力、研發能力對經營績效影響，藉以瞭解影響生技公司經營績效之因素。
2. 探討生技公司組織資本、策略活動對財務能力、研發能力的影響，評估生技公司營運特性與功能性組織能力之關聯。
3. 探討財務能力對研發能力的影響，可使企業瞭解生技公司財務能力如何影響研發能力。
本研究主要是探討生技公司的經營過程中，整理出營運特性與組織能力的互動模式，以及營運特性與組織能力對經營績效的影響。而關於組織資本、策略活動、財務能力、研發能力之間的互動模式做出假設1-5；關於組織資本、策略活動、財務能力、研發能力對生技公司經營績效做出假設6-9。
本研究於民國91年9月透過The Bioworld Online生技資料庫中取得包含世界各國生技公司原始資料共1711筆，並運用複回歸進行統計分析。
研究結果發現（1）組織資本會對生技公司財務能力產生影響，（2）組織資本會對生技公司研發能力產生影響，（3）策略活動會對生技公司財務能力產生影響，（4）策略活動會對生技公司研發能力產生影響，（5）財務能力會對生技公司研發能力產生影響，（6）組織資本會對生技公司經營績效產生影響，（7）財務能力會對生技公司經營績效產生影響，（8）研發能力會對生技公司經營績效產生影響，（9）策略活動會對生技公司經營績效產生影響。鑑於此結果，本研究建議生技公司在經營的過程中，除了以往所強調的研發能力外，更要重視組織資本、策略活動、財務能力對於經營績效的影響，以及如何透過組織資本、策略活動來促進財務能力、研發能力的形成。

Due to IT industry matured, the governments around the world view the development of biotech industry as extremely important developmental goals. The academy and practice also are eager to understand the developments of biotech industry and biotech firms. Although the increasing importance of the biotech industry, little has been done in the literature in examining the relationships among the organizational capital, strategic activities, financial capability, R&D capability, and the business performance of the firms. Therefore, this study attempts to fill the gap in the literature by providing an integrative research framework through extensive literature review to identify the key determinants and to examine the relationships among these determinants, and the business performance of the firms. Based on these determinants, hypotheses were proposed and then examined through an empirical study.
The population in the study originated from the database of The Bioworld Online. The profiles of 1711 firms were collected during September 2002.
The major finding of this study include: According to results of the regression analyses：First, the results show support for the direct effects of organizational capital and strategic activities on financial capability and R&D capability. Secondly, the results suggest that organizational capital, strategic activities, financial capability and R&D capability have direct impacts on the firms’ business performance. Finally, the results also show direct effects of financial capability on R&D capability.

Appiah-Adu, K. and A. Ranchhod (1998), Market Orientation and Performancec in the Biotechnology Industry：An Exploratory Empirical Analysis, Technology Analysis ＆ Strategic Management, 10(2),197-210.
Badrinath, S. G., G. Gay and J. R. Kale (1989), Patterns of Institutional Investment, Prudence, and The Managerial “Safety-Net”hypothesis, The Journal of Risk and Insurance, 56, 605-629.
Bartholomew, S. (1997), National systems of biotechnology innovation：complex interdependence in the global system, Journal of international business studies, 2, 241-266.
Baysinger, B., R. Kosnik and T. Turk (1991), Effects of Board and Ownership Structure on Corporate R&D Strategy, Academy of Management Journal, 34,205-214.
Beaver, W. (1998), Financial Reporting：an accounting revolution (3rd), Prentice Hall.
Bourdieu, P. (1986), The forms of capital-Handbook of theory.and research for the sociology of education, New York：Greenwood Press, 241-258.
Booz, Allen & Hamilton (1982), New products management for the 1980s, New York: Booz, Allen & Hamilton Inc.
Brickley, J. A., R. C. Lease and C. W. Smith Jr. (1988), Ownership Structure and Finance Economics, Journal of Finance Economics, 267-291.
Casper, S. (2000), Institutional Adaptive ness, Technology Policy, and the Diffusion of New Business Model：The Case of German Biotechnology, Organization Studies, 21(5), 887-914.
Crawford, C. M. (1994), New Products Management (4th), Irwin.
Coleman, J. S. (1988), Social capital in the creation human capital, American Journal of Sociology, 94, 95-120.
Cooper. R. G. and E. J. Kleinschmidt (1995), Benchmarking The Firm's Critical Success Factors in New Product Development, Journal of Product Innovation Management, 12, 374-391.
Estades, J. and S. V. Ramani (1998), Technological Competence and the Influence of Networks：A comparative Analysis of New Biotechnology Firms in France and Britain, Technology Analysis ＆ Strategic Management, 10(4),483-495.
Fildes, R. A. (1990), Strategic challenges in commercializing biotechnology, California Management Review, 32(3), 63-72.
Fowler, L. K. and R. D. Schmidt (1988), Tender Offers, Acquisition, and Subsequent Performance in Manufacturing Firm, Academy of Management Journal, 31(4), pp962-974.
Greis, N. P.,M. D. Dibner and A. S. Bean (1995), External partnering as a response to innovation barriers and global competition in biotechnology, Research Policy, 24, 609-630.
Hall, L. A. and S. Bagchi-Sen (2002), A study of R&D, innovation, and business performance in the Canadian biotechnology industry, Technovation, 22, 231-244.
Hamel, G., L. Yves and C. K. Prahalad (1989), Collaborate with your competitors and win, Harvard Business Review, 67(1), 133-139.
Janszen, F. H.A. and G. H. Degenaars (1998), A dynamic analysis of the relations between the structure and the process of National Systems of Innovation using computer simulation；the case of the Dutch biotechnological sector, Research Policy, 27, 37-54.
Kim, W. C., P. Hwang, and W.P. Burgers (1993), Multinationals' Diversification and the Risk-Return Trade-off", Strategic Management Journal, 14, .275-286.
Lamb, C. W., J. F. Hair Jr.and C. McDaniel (1993), Principle of marketing (2nd ed.), College Division South-Western Publishing Co,304-320.
Malnight, T. W. (1996), The transition from decentralized to network-based MNC structures： An evolutionary perspective, Journal of International Business Studies, 1,43-65.
Martens, B. and T. Saretzki (1995), Industrial biotechnology in Austria, Germany, and Switzerland：Empirical Patterns of Its Relevance and Its Historical Development, Technological Forecasting and Social Change, 50, 69-77.
Martens, B. and T. Saretzki (1995), Development of biotechnology in German-Speaking Countries：An analysis Based on Economic and Occupational Data, 48, 45-57.
McCutchen Jr, W. W. ＆ P. M. Swamidass (1996), Effect of R＆D expenditures and funding strategies on the market value of biotech firms, Technology management, 12, 287-299.
McMillan, G. S.,F. Narm and D. L. Deeds (2000), An analysis of the critical role of public science in innovation：the case of biotechnology, Research Policy, 29, 1-8.
Momma, S. and M. Sharp (1999), Developments in new biotechnology firms in Germany, Technovation, 19, 267-282.
Oliver, A. L. (2001), Strategic Alliance and the learning life-cycle of biotechnology firms, Organization studies, 22(3), 467-489.
Pisano, G. P.,W. Shan and D. J. Teece (1988), Joint Ventures and collaboration in the biotechnology industry. In: Mowery, D. (Ed), International Collaborative Ventures in U.S. Manufacturing, Ballinger Publishing Co., Cambridge, MA.
Porter, M.E. and R. Fuller (1986), Competition in Global Industries, Boston, MA: Harvard Business School Press.
Powell, W. W., K. W. Koput and L. Smith-Doerr (1996), Interorganizational Collaboration and the locus of innovation：Networks of Learning in Biotechnology, Administrative Science Quarterly, 41, 116-145.
Ramani, S. (2002), Who is interested in biotech? R&D strategies, knowledge base, and market sales of Indian biopharmaceutical firm, Research policy, 31, 381-398.
Shalhevet, S.,N. Haruvy and I. Spharim (2001), Management strategies for agricultural biotechnology in small countries：A case study of Israel, Biotechnology Advances, 19, 539-554.
Swann, P. and M. Prevezer (1996), A comparison of the dynamics of industrial clustering in computing and biotechnology, Research Policy, 25, 1139-1157.
Thorelli, H. B. (1986), Networks: Between Markets and Hierarchies, Strategic Management Journal, 7, 37-51.
Viana da Cunha, N. C. and E. M. Fracasso (1999), University-enterprise interaction in biotechnology in the south of Brazil, Journal of Knowledge Management, 3(1), 66-74.
Walsh, V., J. Niosi and P. Mustar (1995), Small-firm formation in biotechnology：a comparison of France, Britain and Canada, Technovation, 15(5), 303-327.
伍忠賢（1998），企業購併聖經，遠流出版社。
江晃榮（2001），不可思議的生物科技，台北新店。
財團法人生物技術開發中心（1998），台灣生物技術產業1997/1998。
財團法人生物技術開發中心（2000），2000年生物技術產業年鑑。
黃俊英（1999），企業研究方法，台灣東華出版社。
經濟部工業局（2002），2002生技產業白皮書。
蔡敦浩、葉匡時、俞慧芸（1993），從社會資本學說論我國產業政策之發展方向，研考雙月刊，17-1，44-56。
鄭丁旺（2002），中級會計學7版。
謝劍平（2002），財務管理，智勝出版社。
蘇遠志（1997），台灣生物技術之現況與展望，台灣科技政策研討會。